References
- Abbassi V, Lowe C U, Calcagno P L. Oculo-cerebro-renal syndrome: A review. Am J Dis Child 1968; 115: 145–68
- Lowe C U, Terrey M, MacLachan E A. Organic aciduria, decreased renal ammonia production, hydrophthalmos, and mental retardation: A clinical entity. Am J Dis Child 1952; 83: 164–84
- Bickel H, Thursby-Pelham D C. Hyper-amino-aciduria in Lignac-Fanconi disease in galactosaemia and in an obscure syndrome. Arch Dis Child 1954; 29: 224–31
- Lamy M, Frezal J, Rey J, Larsen C. Étude métabolique du syndrome de Lowe. Rev Fr Etude Clin Biol 1962; 7: 271–83, (In French.)
- LeFebvre G, Biserte G, Woillez M, et al. Étude clinique génétique and biologique du syndrome de Lowe-Bickel. Pediatrie 1957; 12: 527–34, (In French.)
- Richards W, Donnel G N, Wilson W A, Stowens D, Perry T. The oculo-cerebro-renal syndrome of Lowe. Am J Dis Child 1965; 109: 185–203
- Silver D N, Lewis R A, Nussbaum R L. Mapping the Lowe oculocerebrorenal syndrome to Xq24-q26 by use of restriction fragment length polymorphism. J Clin Invest 1987; 79: 282–5
- Attree O, Olivos I M, Okabe I, et al. The Lowe's oculocerebrorenal syndrome gene encodes a protein highly homologous to inositol polyphosphate-5-phosphatase. Nature 1992; 358: 239–42
- Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156–9
- Tso J Y, Sun X-H, Kao T-H, Reece K S, Wu R. Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNA: Genomic complexity and molecular evolution of the gene. Nucleic Acids Res 1985; 13: 2485–502
- Nomura S, Wills A J, Edwards D R, Heath J K, Hogan BL M. Developmental expression of 2ar (os-teopontin) and SPARC (osteonectin) RNA as revealed by in situ hybridization. J Cell Biol 1988; 106: 441–50
- Hooft C, Valcke R, Herpol J. Étude clinique du syndrome de Lowe. Acta Paediat Belag 1964; 18: 197–272
- Curtin V T, Joyce E E, Ballin N. Ocular pathology in the oculo-cerebro-renal syndrome of Lowe. Am J Ophthalmol 1967; 64: 533–43
- Endres W, Schaub J, Stefani F H, Wirtz A, Zahn V. Cataract in a fetus at risk for oculo-cerebro-renal syndrome (Lowe). Klin Wochenschr 1977; 55: 141–4
- Ginsberg J, Bove K E, Fogelson M H. Pathological features of the eye in the oculocerebrorenal (Lowe) syndrome. J Pediatr Ophthalmol Strabismus 1981; 18: 16–24
- Witzleben C L, Schoen E J, Tu W H, McDonald L W. Progressive morphologic renal changes in the oculo-cerebro-renal syndrome of Lowe. Am J Med 1968; 44: 319–24
- Ores R O. Renal changes in oculo-cerebro-renal syndrome of Lowe. Electron microscopic study. Arch Pathol 1970; 89: 221–5
- Yamashina I, Yoshida H, Fukui S, Funakoshi I. Biochemical studies on Lowe's syndrome. Mol Cell Biochem 1983; 52: 107–24
- Habib R, Bargeton E, Brissaud H-E, Raynaud J, Le Ball J-C. Constatations anatomiques chez un enfant atteint d'un syndrome de Lowe. Arch Fr Pediatr 1962; 19: 945–60
- Matin M A, Sylvester P E. Clinicopathological studies of oculo cerebrorenal syndrome of Lowe Terrey and MacLachlan. J Ment Defic Res 1980; 24: 1–16
- Chutorian A, Rowland L P. Lowe's syndrome. Neurology 1966; 16: 115–22
- Banerjee A K, Allen I V, McKee P. Oculo-cerebro-renal syndrome: Failure to demonstrate specific neuropathological abnormalities in four cases. Ir J Med Sci 1982; 15: 42–5
- Ross T S, Jefferson A B, Mitchell C A, Majerus P W. Cloning and expression of human 75-kDa inositol polyphosphate-5-phosphatase. J Biol Chem 1991; 266: 20283–9